MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-27-2026
Inogen Operating Expenses 2011-2026 | INGN
Annual Operating Expenses Inogen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 184 M | 197 M | 236 M | 239 M | 167 M | 150 M | 152 M | 141 M | 93.6 M | 74.4 M | 61.2 M | 45 M | 34.5 M | 23.1 M | 16.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 239 M | 16.4 M | 121 M |
Quarterly Operating Expenses Inogen
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.4 M | 47.5 M | 44 M | - | 49.1 M | 49.8 M | 50.6 M | - | 80.5 M | 45.8 M | 52.6 M | - | 53.1 M | 49.1 M | 48.6 M | - | 41.3 M | 38.7 M | 42 M | - | 35 M | 35.1 M | 40.5 M | - | 35.2 M | 38.1 M | 39.6 M | - | 38.4 M | 34.4 M | 29 M | - | 24.8 M | 23.1 M | 20.2 M | - | 19.7 M | 18.2 M | 18 M | - | 15.7 M | 15.5 M | 13.5 M | - | 11.1 M | 11.2 M | 10.4 M | - | 8.76 M | 8.66 M | 7.48 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 80.5 M | 7.48 M | 33.1 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 12.42 | -4.46 % | $ 1.86 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 38.55 | 0.13 % | $ 5.74 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 8.31 | 1.4 % | $ 597 M |  Israel |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 9.61 | -0.62 % | $ 1.3 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.26 | -0.12 % | $ 205 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 41.66 | -3.09 % | $ 1.29 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.19 | -1.41 % | $ 156 M |  France |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
121 M | $ 29.15 | -0.24 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.27 | -0.82 % | $ 113 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.59 | 0.3 % | $ 122 M | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.5 | -4.78 % | $ 51.4 M | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
41.9 M | $ 0.81 | 1.91 % | $ 44.1 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 175.78 | -3.51 % | $ 13.2 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 3.7 | -8.31 % | $ 783 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 110.91 | -1.94 % | $ 193 B | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 13.49 | -0.55 % | $ 872 M | Israel |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 72.61 | 0.55 % | $ 107 B | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.4 | -0.71 % | $ 22.6 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 100.27 | -4.6 % | $ 1.27 B | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.26 | -2.16 % | $ 1.37 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 17.55 | -5.03 % | $ 412 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 83.7 | -1.78 % | $ 48.9 B | USA |
 |
Pulmonx Corporation
LUNG
|
120 M | $ 1.61 | 12.07 % | $ 63 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 64.29 | -1.49 % | $ 3.51 B |  Britain |